SRPT:NASDAQ
Sarepta Therapeutics Inc
$20.94
arrow_downward
-6.93%(-1.56) 1D
$20.93
arrow_downward
-0.04% (-0.0086)bedtimeAfter hours
Closed: Sep 8, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SRPT...
Open
$19.86
High
$21.32
Low
$19.51
Mkt. cap
2.21B
Avg. vol.
3.09M
Volume
0.00
52-wk high
$25.32
52-wk low
$14.69
EPS
-$1.66
Beta
0.27
Shares outstanding
105.63M
No. of employees
835
Open
$19.86
High
$21.32
Low
$19.51
Mkt. cap
2.21B
Avg. vol.
3.09M
Volume
0.00
52-wk high
$25.32
52-wk low
$14.69
EPS
-$1.66
Beta
0.27
Shares outstanding
105.63M
No. of employees
835
News stories
From web sources and news partners
Stock Titan
·
5 hours ago
Sarepta (SRPT) COO reports tax share withholding after RSU vesting
News Corp
·
9 hours ago
Novartis Stock Tanks Following Third Major Pipeline Setback
Reuters
·
10 hours ago
Dyne, Sarepta shares tumble as Novartis setback weighs on muscle disease drug developers
Investing.com
·
11 hours ago
Jefferies reiterates Sarepta Therapeutics stock rating on trial data outlook
Profile
Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively. As of 2023, the company has four approved drugs. Wikipedia
About Sarepta Therapeutics Inc